Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07525076 · ClinicalTrials.gov registry record · NA
Implementation of an Opt-Out Testing and Rapid Diagnostic Strategy for Syphilis and HIV in Pregnant Patients Presenting to the Emergency Department
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Not yet
- Registry status
- NA
- Development phase
- 1,400
- Enrollment target
NCT07525076 is a NA study that has not yet begun recruiting, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 1,400 participants.
The verdict
NCT07525076, a NA study, has not yet begun recruiting, sponsored by The University of Texas Health Science Center, Houston.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 1,400 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate infection detection and treatment initiation rates for syphilis and HIV before and after integration of the Chembio DPP® HIV-Syphilis rapid POC test into an ongoing Emergency Department (ED) testing program and to determine whether dual rapid testing improves early initiation of HIV therapy in pregnant patients with newly identified HIV infection.
Interventions
- DIAGNOSTIC_TEST Chembio HIV/Syphilis rapid Point of Care (POC) test
- DIAGNOSTIC_TEST Laboratory-based HIV and syphilis testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,400 participants |
| Start Date | 2026-04-15 |
| Est. Completion | 2028-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07525076
The ClinicalTrials.gov registry entry for NCT07525076 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 1,400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Chembio HIV/Syphilis rapid Point of Care (POC) test is the first listed.
NCT07525076 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07525076 about?
NCT07525076 is a clinical study titled "Implementation of an Opt-Out Testing and Rapid Diagnostic Strategy for Syphilis and HIV in Pregnant Patients Presenting to the Emergency Department". The purpose of this study is to evaluate infection detection and treatment initiation rates for syphilis and HIV before and after integration of the Chembio DPP® HIV-Syphilis rapid POC test into an ongoing Emergency Department (ED) testing program and to determine whether dual rapid testing improves...
What is the current status of trial NCT07525076?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 1,400 participants. The study started on 2026-04-15. Estimated completion is 2028-05-31.
What interventions are being tested in trial NCT07525076?
The interventions under investigation include: Chembio HIV/Syphilis rapid Point of Care (POC) test (DIAGNOSTIC_TEST), Laboratory-based HIV and syphilis testing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07525076?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.